venBio Global Strategic Fund III, L.P.

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 37% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
venBio Global Strategic Fund III, L.P.'s trades of Artiva Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-22 2024-07-22
B Purchase
80,415 -44.9%
288.63
US$3,217,869 		80,415 -44.9% 288.63 US$3,217,869
2022-05-27 2022-05-25
S Sale
48,056 -45.5%
260.92
US$3,794,147 		48,056 -45.5% 260.92 US$3,794,147
2021-10-25 2021-10-25
B Purchase
74,968 +20.6%
150.17
US$3,745,442 		74,968 +20.6% 150.17 US$3,745,442